Antidepressant augmentation: conclusions and recommendations.
作者信息
Sussman N, Joffe R T
机构信息
Department of Psychiatry, New York University School of Medicine, New York 10021, USA.
出版信息
J Clin Psychiatry. 1998;59 Suppl 5:70-3.
PMID:9635551
Abstract
摘要
相似文献
1
Antidepressant augmentation: conclusions and recommendations.
J Clin Psychiatry. 1998;59 Suppl 5:70-3.
2
Potentiation strategies for treatment-resistant depression.
Acta Psychiatr Scand Suppl. 2005(428):14-24, 36. doi: 10.1111/j.1600-0447.2005.00676.x.
3
Introduction: augmentation of antidepressant medication.
J Clin Psychiatry. 1998;59 Suppl 5:3-4; discussion 70-3.
4
Augmentation strategies for treatment-resistant depression: a literature review.
J Clin Pharm Ther. 2007 Oct;32(5):415-28. doi: 10.1111/j.1365-2710.2007.00846.x.
5
The use of thyroid supplements to augment antidepressant medication.
J Clin Psychiatry. 1998;59 Suppl 5:26-9; discussion 30-1.
6
Treating antidepressant nonresponders with augmentation strategies: an overview.
J Clin Psychiatry. 1998;59 Suppl 5:5-12; discussion 13-5.
7
Possible augmentation of antidepressant response by buspirone.
J Clin Psychiatry. 1991 May;52(5):217-20.
8
Biochemical effects of antidepressant augmentation.
Arch Gen Psychiatry. 1995 Feb;52(2):156. doi: 10.1001/archpsyc.1995.03950140074012.
9
Biochemical and clinical effects of buspirone augmentation.
J Clin Psychiatry. 1994 Jun;55(6):264.
10
Augmentation regimens for depression.
J Clin Psychiatry. 1991 May;52 Suppl:21-7.
引用本文的文献
1
Medicinal Cannabis and Central Nervous System Disorders.
Front Pharmacol. 2022 Apr 21;13:881810. doi: 10.3389/fphar.2022.881810. eCollection 2022.
Zotero 插件